Characteristics of autoimmune reactions in chronic cardiac failure of different etiology

Abstract

Aim. To characterize autoimmune reactions in patients with chronic cardiac failure (CCF) of different etiology.
Material and methods. Basic markers of immune activation were measured in 43 patients with coronary heart disease stage I-IIB (NYHA FC I-IV) and 44 patients with dilated cardiomyopathy (DCMP) stage I-IIB (NYHA FC I-IV). Antibodies to myocardial tissue were studied with indirect immunofluorescence. Echocardiography was made by standard recommendations with evaluation of systolic and diastolic left ventricular function. Concentrations of C-reactive protein, IgG, IgA, IgM were estimated nephelometrically. Enzyme immunoassay studied serum levels of IL-8, IL-2R, IL-6, IL-18, IL-10, IFN-gamma, endothelin.
Results. Patients with DCMP had higher titers of antimyocardial autoantibodies than in coronary heart disease (CHD) reflecting more severe autoimmune inflammation. In CHD endothelial, systolic and diastolic dysfunctions severity correlated with severity of inflammation.
Conclusion. Some characteristics of autoimmune reactions in CCF determine severity of the disease course.

References

  1. Ikonomidis I., Lekakis J., Vamvakou G. et al. IgA anticardiolipin antibody is associated with the extent of daily-life ischaemia in patients with chronic coronary artery disease. Heart 2007; 93 (11): 1412-1413.
  2. Белецкая Л. В., Баранова Ф. С., Могилевский Г. М. и др. Иммунопатологическое исследование миокарда при дилатационной кардиомиопатии. Арх. пат. 1992; 4: 24-26.
  3. Pankuweit S., Hufnagel G., Eckhardt H. et al. Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med. Klin. 1998; 93 (4): 223-228.
  4. Biliсska Z. T., Caforio A. L., Grzybowski J. et al. Organ-specific cardiac autoantibodies in dilated cardiomyopathy. Frequency and clinical correlates in Polish patients. Eur. Heart. J. 1995; 16 (12): 1907-1911.
  5. Matsui S., Larsson L., Hayase M. et al. Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function. J. Mol. Cell. Cardiol. 2006; 41 (1): 78-85.
  6. Gao Y., Liu H. R., Zhao R. R., Zhi J. M. Autoantibody against cardiac beta1-adrenoceptor induces apoptosis in cultured neonatal rat cardiomyocytes. Acta Biochim. Biophys. Sin. 2006; 38 (7): 443-449.
  7. Wallukat G., Reinke P., Dцrffel W. V. et al. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int. J. Cardiol. 1996; 54 (2): 191-195.
  8. Wang Z., Liao Y., Yuan J. et al. Analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in anti-CD4 monoclonal antibody treated mice with autoimmune cardiomyopathy. J. Huazhong Univ. Sci. Technol. Med. Sci. 2008; 28 (4): 409-414.
  9. Staudt A., Bцhm M., Knebel F. et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106 (19): 2448-2453.
  10. Иванова О. В., Балахонова Т. В., Соболева Г. Н. и др. Состояние эндотелийзависимой вазодилатации плечевой артерии у больных гипертонической болезнью, оцениваемое с помощью ультразвука высокого разрешения. Кардиология 1997; 7: 41-45.
  11. Panichi V., Taccola D., Rizza G. M. et al. Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients. Nephron. Clin. Pract. 2006; 102 (2): c51-c58.
  12. Sigusch H. H., Lehmann M. H., Reinhardt D. et al. Chemotactic activity of serum obtained from patients with idiopathic dilated cardiomyopathy. Pharmazie 2006; 61 (8): 706-709.
  13. Damеs J. K., Eiken H. G., Oie E. et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc. Res. 2000; 47 (4): 778-787.
  14. Seino Y., Ikeda U., Sekiguchi H. et al. Expression of leukocyte chemotactic cytokines in myocardial tissue. Cytokine 1995; 7 (3): 301-304.
  15. Abou-Shousha S. A., Youssef A. I. Interleukin-2 regulatory effect on P-selectin and interleukin-8 production in patients with chronic renal failure. Egypt. J. Immunol. 2006; 13 (1): 11-18.
  16. Chang H. J., Chung J., Choi B. J. et al. The origin of proinflammatory cytokines in patients with idiopathic dilated cardiomyopathy. J. Korean Med. Sci. 2003; 18 (6): 791-796.
  17. Satoh M., Nakamura M., Akatsu T. et al. C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur. J. Heart Fail. 2005; 7 (5): 748-754.
  18. Plenz G., Song Z. F., Tjan T. D. et al. Activation of the cardiac interleukin-6 system in advanced heart failure. Eur. J. Heart Fail. 2001; 3 (4): 415-421.
  19. Galkina E. V., Nazarov P. G., Polevschikov A. V. et al. Interactions of C-reactive protein and serum amyloid P component with interleukin-8 and their role in regulation of neutrophil functions. Rus. J. Immunol. 2000; 5 (4): 363-374.
  20. Nacinoviж-Duletiж A., Stifter S., Dvornik S. et al. Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. 1: Int. J. Lab. Hematol. 2008; 30 (3): 230-239.
  21. Stдger S., Maroof A., Zubairi S. et al. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cell. Eur. J. Immunol. 2006; 36 (7): 1764-1771.
  22. Yamaoka-Tojo M., Tojo T., Inomata T. et al. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J. Card. Fail. 2002; 8 (1): 21-27.
  23. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 2008; 79 (3): 360-376.
  24. Okamoto M., Kato S., Oizumi K. et al. Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of intestitial pneumonia. Blood 2002; 99 (4): 1289-1298.
  25. Limas C. J., Hasikidis C., Iakovou J. et al. Prognostic significance of soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Eur. J. Clin. Invest. 2003; 33 (6): 443-448.
  26. Ballow M., Xiang S., Greenberg S. J. et al. Retinoic acid-induced modulation of IL-2 mRNA production and IL-2 receptor expression on T cells. Int. Arch. Allergy Immunol. 1997; 113 (1-3): 167-169.
  27. Michowitz Y., Arbel Y., Wexler D. et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int. J. Cardiol. 2008; 125 (3): 347-351.
  28. Schwedler S. B., Kuhlencordt P. J., Ponnuswamy P. P. et al. Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species. Atherosclerosis 2007; 195 (2): e76-e84.
  29. Schwartz R., Osborne-Lawrence S., Hahner L. et al. C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ. Res. 2007; 100 (10): 1452-1459.

Copyright (c) 2009 Zykov K.A., Tatenkulova S.N., Masenko V.P., Kuznetsova T.V., Rvacheva A.V., Belenkov Y.N., Zykov K.A., Tatenkulova S.N., Masenko V.P., Kuznetsova T.V., Rvacheva A.V., Belenkov Y.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies